Supplementary Figure 1 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation

2026 Open access

Read full text
Authors: Vincent Rondeau, Suraj Bansal, Marco M. Buttigieg, Andy G.X. Zeng, Darryl Y. Chan, Michelle Chan‐Seng‐Yue, Jin Liqing, Jessica L. McLeod, Meghan Kates, Elisa Donato, Patrick Stelmach, Caitlyn Vlasschaert
+15 more Yitong Yang, Aarushi Gupta, Sofia Genta, Enrique Sanz‐García, Liran I. Shlush, Mauricio Ribeiro, Marcus O. Butler, Sagi Abelson, Mark D. Minden, Samuel D. Saibil, Steven M. Chan, Michael J. Rauh, Andreas Trumpp, John Edgar Dick, Robert J. Vanner
DOI: 10.1158/0008-5472.31345379
Cited by: 0

Abstract

Mice with 20% Tet2-mutant hematopoiesis do not show an attenuation of tumor growth in immunotherapy response rate

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses T-cell and B-cell Immunology

Publication details

Publication date
16 February 2026
Language
EN